About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Novo Nordisk CEO to step down as competition weighs on Wegovy maker's share price
Tags Breaking News: Europe Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
Tags Breaking News: Politics GSK plc Novo Nordisk A/S
From CNBC.com News
Why Americans pay so much more for prescription drugs
Tags Politics LILLY DRN Drug Retail
From CNBC.com News
Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
Tags LILLY DRN Healthy Returns Social issues
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags Business Abbvie Inc LILLY DRN
From CNBC.com News
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
Tags Hims & Hers Health Inc Make It Make It: Next Gen Investing
From CNBC.com News
Hims & Hers brings former Amazon executive into C-suite
Tags Enterprise Breaking News: Technology Hims & Hers Health Inc
From CNBC.com News
Cramer's week ahead: Earnings from Disney, Palantir and Uber
Tags Investing Markets Novo Nordisk A/S
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Roche Holding AG Mergers LILLY DRN
From CNBC.com News
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Tags Health care industry Biotechnology Novo Nordisk A/S
From CNBC.com News
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
Tags Hims & Hers Health Inc US: News Business
From CNBC.com News
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
Tags Pharmaceuticals Health care industry Biotechnology
From CNBC.com News
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
Tags UnitedHealth Group Inc Pfizer Inc Bristol/Myers Squibb Co
From CNBC.com News
5 European stocks to watch this earnings season as Trump's tariffs hit
Tickers OIL
Tags Airlines Oil and Gas Boeing Co
From CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
Tags Health & Science Biotech and Pharmaceuticals AstraZeneca PLC
From CNBC.com News
CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine
Tags Asia Markets Novo Nordisk A/S Markets
From CNBC.com News
Pfizer scraps daily weight loss pill after liver injury in one patient
Tags Health care industry Novo Nordisk A/S Biotechnology
From CNBC.com News
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback
Tags Novo Nordisk A/S Pharmaceuticals Breaking News: Politics
From CNBC.com News
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
Tags US: News Business Social issues
From CNBC.com News
The biggest winners and losers in Europe as Trump announces sweeping tariffs
Tags HSBC Holdings PLC US: News Europe News
From CNBC.com News
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
Tags Bayer AG Roche Holding AG Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
Tags Biotech and Pharmaceuticals Health & Science Science
From CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
Tags Novo Nordisk A/S Biotechnology LILLY DRN
From CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Tags LILLY DRN Novo Nordisk A/S Biotechnology
From CNBC.com News
CNBC Daily Open: Consumers and CFOs alike are expecting a recession in the U.S.
Tags Market Outlook SAP AG Novo Nordisk A/S
From CNBC.com News
CNBC Daily Open: Fears of a U.S. recession intensify among consumers and CFOs
Tags Daily Open Tesla Inc World Markets
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
Tags Science Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Software giant SAP becomes Europe's most valuable firm amid German stock market boom
Tags LVMH Moet Hennessy Louis Vuitton SE Europe Markets Markets
From CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Tags Structure Therapeutics Inc US: News Business
From CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
Tags Pharmaceuticals Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.